Bender James G. 4/A
4/A · ImmunoCellular Therapeutics, Ltd. · Filed Feb 22, 2013
Insider Transaction Report
Form 4/AAmended
Bender James G.
VP, Product Development & Mfg.
Transactions
- Sale
Common Stock
2012-06-01$3.60/sh−4,900$17,640→ 1,279 total - Sale
Common Stock
2012-06-01$3.61/sh−600$2,166→ 679 total - Sale
Common Stock
2012-06-01$3.59/sh−1,500$5,385→ 6,179 total
Footnotes (1)
- [F1]This Form 4 is being amended to correct a calculation error in the Amount of Securities Beneficially Owned Following Reported Transactions.